These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 2625103)

  • 1. [Plasma prostaglandins E, E2 and F2a in nasopharyngeal carcinoma (NPC)].
    Chen BS
    Zhonghua Zhong Liu Za Zhi; 1989 Jul; 11(4):248-50. PubMed ID: 2625103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beta-2-microglobulin (beta 2M) as a tumor marker in nasopharyngeal carcinoma.
    Lee JK; Tsai SC; Hsieh JF; Ho YJ; Sun SS; Kao CH
    Anticancer Res; 2000; 20(6C):4765-8. PubMed ID: 11205215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Serum beta 2-microglobulin determination in nasopharyngeal carcinoma patients. An analysis of 139 cases].
    Luo ZM
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 1992; 27(4):239-40, 256. PubMed ID: 1298313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue polypeptide specific antigen (TPS) as a tumor marker in nasopharyngeal carcinoma.
    Sun SS; Hsieh JF; Tsai SC; Ho YJ; Kao CH
    Anticancer Res; 2000; 20(6C):4661-3. PubMed ID: 11205197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of plasma Epstein-Barr virus (EBV) DNA levels and serum EBV immunoglobulin A/virus capsid antigen antibody titers in patients with nasopharyngeal carcinoma.
    Shao JY; Li YH; Gao HY; Wu QL; Cui NJ; Zhang L; Cheng G; Hu LF; Ernberg I; Zeng YX
    Cancer; 2004 Mar; 100(6):1162-70. PubMed ID: 15022282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical significance of plasma PGE2 levels in pre- and post-operative patients with laryngeal carcinoma].
    Li SZ; Liu H; Xu XL
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2000 Mar; 14(3):106-7. PubMed ID: 12541407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma concentrations of prostaglandins E2 and F2a in asthmatic patients.
    Godard P; Chantreuil J; Clauzel AM; Crastes de Paulet A; Michel FB
    Respiration; 1981; 42(1):43-51. PubMed ID: 6949240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevation of plasma osteopontin level in patients with undifferentiated nasopharyngeal carcinoma.
    Wong TS; Kwong DL; Sham J; Wei WI; Kwong YL; Yuen AP
    Eur J Surg Oncol; 2005 Jun; 31(5):555-8. PubMed ID: 15922893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inverse correlation between serum PGE2 and T classification in head and neck cancer.
    Hambek M; Baghi M; Wagenblast J; Schmitt J; Baumann H; Knecht R
    Head Neck; 2007 Mar; 29(3):244-8. PubMed ID: 17123309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of serum biomarkers for nasopharyngeal carcinoma by proteomic analysis.
    Wei YS; Zheng YH; Liang WB; Zhang JZ; Yang ZH; Lv ML; Jia J; Zhang L
    Cancer; 2008 Feb; 112(3):544-51. PubMed ID: 18085639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arachidonic acid metabolites in a nephroblastoma associated with paraneoplastic hypercalcemia.
    Calò L; Cantaro S; Vianello A; Vido L; Rizzoni G; Borsatti A
    Prostaglandins; 1986 Jul; 32(1):116-20. PubMed ID: 3020618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of CYFRA 21-1 and tissue polypeptide specific antigen (TPS) for detecting nasopharyngeal carcinoma.
    Tai CJ; Liu FY; Liang JA; Yang SN; Tsai MH; Kao CH
    Anticancer Res; 2002; 22(6B):3793-6. PubMed ID: 12552995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathologic significance of plasma matrix metalloproteinase-2 and -9 levels in patients with undifferentiated nasopharyngeal carcinoma.
    Wong TS; Kwong DL; Sham JS; Wei WI; Kwong YL; Yuen AP
    Eur J Surg Oncol; 2004 Jun; 30(5):560-4. PubMed ID: 15135487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High frequency of promoter hypermethylation of the death-associated protein-kinase gene in nasopharyngeal carcinoma and its detection in the peripheral blood of patients.
    Wong TS; Chang HW; Tang KC; Wei WI; Kwong DL; Sham JS; Yuen AP; Kwong YL
    Clin Cancer Res; 2002 Feb; 8(2):433-7. PubMed ID: 11839660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of Epstein-Barr virus DNA level in plasma, peripheral blood cell and tumor tissue in nasopharyngeal carcinoma.
    Shao JY; Zhang Y; Li YH; Gao HY; Feng HX; Wu QL; Cui NJ; Cheng G; Hu B; Hu LF; Ernberg I; Zeng YX
    Anticancer Res; 2004; 24(6):4059-66. PubMed ID: 15736452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated plasma big ET-1 is associated with distant failure in patients with advanced-stage nasopharyngeal carcinoma.
    Mai HQ; Zeng ZY; Zhang CQ; Feng KT; Guo X; Mo HY; Deng MQ; Min HQ; Hong MH
    Cancer; 2006 Apr; 106(7):1548-53. PubMed ID: 16518816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Quantitative analysis of Epstein-Barr virus DNA in plasma and peripheral blood cells in patients with nasopharyngeal carcinoma].
    Zhang Y; Gao HY; Feng HX; Deng L; Huang MY; Hu B; Cheng G; Wu QL; Cui NJ; Shao JY
    Zhonghua Yi Xue Za Zhi; 2004 Jun; 84(12):982-6. PubMed ID: 15312530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of Survivin and Livin in nasopharyngeal carcinoma.
    Xiang Y; Yao H; Wang S; Hong M; He J; Cao S; Min H; Song E; Guo X
    Laryngoscope; 2006 Jan; 116(1):126-30. PubMed ID: 16481824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced plasma RNA integrity in nasopharyngeal carcinoma patients.
    Wong BC; Chan KC; Chan AT; Leung SF; Chan LY; Chow KC; Lo YM
    Clin Cancer Res; 2006 Apr; 12(8):2512-6. PubMed ID: 16638860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pre- and postoperative NK cell number and plasma levels of TNF and PGE2 in patients with esophageal carcinoma and their clinical significance].
    Zhou JH; Jiang YG
    Zhonghua Zhong Liu Za Zhi; 1994 Mar; 16(2):132-6. PubMed ID: 7924864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.